Journal Articles Conference Presentations Book Chapters Public Presentations

Electroporation enhances reporter gene expression following delivery of naked plasmid DNA to the lung.

Pringle IA, McLachlan G, Collie DD, Sumner-Jones SG, Lawton AE, Tennant P, Baker A, Gordon C, Blundell R, Varathalingam A, Davies LA, Schmid RA, Cheng SH, Porteous DJ, Gill DR, Hyde SC

The Journal Of Gene Medicine

J Gene Med. 2007 May;9(5):369-80.

Print this page

BACKGROUND: Existing methods of non-viral airway gene transfer suffer from low levels of efficiency. Electroporation has been used to enhance gene transfer in a range of tissues. Here we assess the usefulness of electroporation for enhancing gene transfer in the lungs of mice and sheep.

METHODS: Naked plasmid DNA (pDNA) expressing either luciferase or green fluorescent protein (GFP) was delivered to mouse lungs by instillation. Following surgical visualisation, the lungs were directly electroporated and the level and duration of luciferase activity was assessed and cell types that were positive for GFP were identified in lung cryosections. Naked pDNA was nebulised to the sheep lung and electrodes attached to the tip of a bronchoscope were used to electroporate airway segment bifurcations, Luciferase activity was assessed in electroporated and control non-electroporated regions, after 24 h.

RESULTS: Following delivery of naked pDNA to the mouse lung, electroporation resulted in up to 400-fold higher luciferase activity than naked pDNA alone when luciferase was under the control of a cytomegalovirus (CMV) promoter. Following delivery of a plasmid containing the human polyubiquitin C (UbC) promoter, electroporation resulted in elevated luciferase activity for at least 28 days. Visualisation of GFP indicated that electroporation resulted in increased GFP detection compared with non-electroporated controls. In the sheep lung electroporation of defined sites in the airways resulted in luciferase activity 100-fold greater than naked pDNA alone.

CONCLUSIONS: These results indicate that electroporation can be used to enhance gene transfer in the lungs of mice and sheep without compromising the duration of expression.

Go Back to Publications     View on Pubmed (17410613)    View on Google Scholar


 

Other Publications by these authors
Aerosol delivery of DNA/liposomes to the lung for cystic fibrosis gene therapy.
Davies LA et al. Human Gene Therapy. Clinical Development (2014) Rapid identification of novel functional promoters for gene therapy.
Pringle IA et al. Journal Of Molecular Medicine (Berlin, Germany) (2012) CpG-free plasmid expression cassettes for cystic fibrosis gene therapy.
Pringle IA et al. Biomaterials (2012) Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung.
McLachlan G et al. Gene Therapy (2011) Validation of recombinant Sendai virus in a non-natural host model.
Griesenbach U et al. Gene Therapy (2010) Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects.
Pringle IA et al. Expert Opinion On Biological Therapy (2009)